PRESS RELEASES More events are coming soon. Keyword Search Year: 20202019201820172016201520142013 08/17/20 Summary ToggleTRACON Pharmaceuticals Announces FDA Clearance of ENVASARC Pivotal Trial Printer Friendly PDF Version 08/05/20 Summary ToggleTRACON Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update Printer Friendly PDF Version 08/03/20 Summary ToggleTRACON Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference Printer Friendly PDF Version 07/29/20 Summary ToggleTRACON to Report Second Quarter 2020 Financial Results and Company Highlights on August 5, 2020 Printer Friendly PDF Version 07/16/20 Summary ToggleTRACON Pharmaceuticals Announces Filing of Protocol for ENVASARC Pivotal Trial with the FDA Printer Friendly PDF Version 07/13/20 Summary ToggleTRACON Pharmaceuticals to Host Key Opinion Leader Webinar on Envafolimab for the Treatment of Sarcoma Printer Friendly PDF Version 06/01/20 Summary ToggleTRACON Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference Printer Friendly PDF Version 05/29/20 Summary ToggleTRACON Pharmaceuticals Highlights Updated Envafolimab Results in MSI-H/dMMR Colorectal Cancer and Results from Clinical Trial of Opdivo and Yervoy Combination Therapy in Undifferentiated Pleomorphic Sarcoma Conducted by Alliance for Clinical Trials in Onc Printer Friendly PDF Version 05/14/20 Summary ToggleTRACON Pharmaceuticals Announces Presentation of Positive Clinical Data for Envafolimab in MSI-H/dMMR Cancer at ASCO 2020 Virtual Scientific Program by its Corporate Partners 3D Medicines and Alphamab Printer Friendly PDF Version 05/13/20 Summary ToggleTRACON Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update Printer Friendly PDF Version Pagination First page First Previous page Previous Page 1 Current page 2 Page 3 Page 4 … Next page Next Last page Last
